News and updates


REDEFINE 3 Image from novo nordisk

Status: Open

The study, REDEFINE 3, is looking at a combination of two medicines. REDEFINE 3 is needed to help
us understand how effective these two medicines are for reducing cardiovascular events, such as
heart attacks and stroke. This study is funded and sponsored by Novo Nordisk.

To find out more about the REDEFINE-3 study, please visit or contact the

01392 406289

E.mbrace; Investigational research study at the PRC: Exeter

E.mbrace study campaign image

The PRC Exeter (Based on the Wonford site at the Royal Devon) are currently looking for participants for a clinical research study to assess the effectiveness and safety of an investigational vaccine in the prevention of bloodstream infections. 

Find out more

Life-changing research trials new treatment approach for debilitating spinal condition

BOOST Study North Devon picture press release NIHR

“I’ve seen the expressions on people’s faces change, from a bit miserable to really happy” – life-changing research trials new treatment approach for debilitating spinal condition

A group of patients with a painful spinal condition are benefiting from a new programme of physiotherapist-led classes thanks to research.

The National Institute for Health and Care Research (NIHR)-funded Better Outcomes for Older People with Spinal Trouble (BOOST) study is testing a strength and conditioning programme to see if it is more effective than standard treatment for people with spinal stenosis.

Find out more

Patient Recruitment Centre: Exeter spearheads UK recruitment for multi-site Respiratory Syncytial Virus (RSV) study

Image of Baby with parent

NIHR Patient Recruitment Centre: Exeter is currently the UK’s top recruiting site for a large-scale, multi-site study investigating a new treatment which may help protect babies from serious illness due to RSV infection (respiratory syncytial virus).

Find out more

Last updated: July 11, 2023


Our site uses cookies to help give you a better experience. By continuing to use it you consent to the use of cookies as set out in our privacy policy.